Analytical Techniques in the Analysis of Darunavir and Ritonavir: A Review

Author(s): Goswami Kashish, Parikh Nisha*, Kadikar Hiren

Journal Name: Current Pharmaceutical Analysis

Volume 16 , Issue 5 , 2020


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Darunavir and Ritonavir are amongst the most useful antiretroviral drugs worldwide for treating AIDS (acquired immune deficiency syndrome). This review discussed and summarized the various analytical techniques used in the qualitative and quantitative analysis of darunavir and ritonavir, protease inhibitors (PIs), which have gained importance as antiretroviral drugs. The importance and use of chromatographic techniques for the estimation of darunavir and ritonavir are also discussed herein. This review highlights the various advanced analytical techniques such as spectroscopic, chromatographic, electrophoresis, X-ray powder diffraction and their corresponding methods.

Keywords: Darunavir, ritonavir, anti-retroviral drug, AIDS, analytical techniques, quantitative analysis, qualitative analysis.

[1]
Kanta, V.; Sharma, U.; Mahatma, R. A review on: AIDS and herbal remedies. Int. J. Res. Ayurveda Pharm., 2011, 2(6), 1709-1713.
[2]
Fanales-Belasio, E.; Raimondo, M.; Suligoi, B.; Buttò, S. HIV virology and pathogenetic mechanisms of infection: a brief overview. Ann. Ist. Super. Sanita, 2010, 46(1), 5-14.
[http://dx.doi.org/10.1590/S0021-25712010000100002] [PMID: 20348614]
[3]
Golucci, A.P.; Marson, F.A.; Valente, M.F.; Branco, M.M.; Prado, C.C.; Nogueira, R.J. Influence of AIDS antiretroviral therapy on the growth pattern. J. Pediatr., 2018, 65(2), 1-11.
[PMID: 29660296]
[4]
Chemburkar, S.R.; Bauer, J.; Deming, K.; Spiwek, H.; Patel, K. Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development. Org. Process Res. Dev., 2000, 4(5), 413-417.
[http://dx.doi.org/10.1021/op000023y]
[5]
Shankpal, P.D.; Hotwani, J.H.; Chitnis, K.A.; Limaye, A.S. Concept of Anti-HIV therapy and its applications in a resource-poor setting. Int. J. Pharm. Sci. Res., 2012, 4(1), 360-370.
[6]
Curran, A.; Marti, R.; Lopez, R.M.; Perez, M.; Eynde, E.; Crespo, M. Darunavir and ritonavir total and unbound concentrations in HIV-HCV co infected patients with hepatic cirrhosis.13th International Workshop on Clinical Pharmacology of HIV Therapy; April 16-18th. , 2012. Barcelona, Spain.
[7]
Dickinson, L.; Jackson, A.; Garvey, L. Population pharmacokinetic modeling of plasma and intracellular once daily ritonavir-boosted darunavir in HIV-infected patients. 11th Int Workshop Clin Pharmacol HIV Ther, MiamiApril 13-15, 2011
[8]
Siddiqui, M.R.; AlOthman, Z.A.; Rahman, N. Analytical techniques in pharmaceutical analysis: a review. Arab. J. Chem., 2017, 10, S1409-S1421.
[http://dx.doi.org/10.1016/j.arabjc.2013.04.016]
[9]
Rahman, N.; Azmi, S.N.H.; Wu, H.F. The importance of impurity analysis in pharmaceutical products: an integrated approach. Accredit. Qual. Assur., 2006, 11, 69-74.
[http://dx.doi.org/10.1007/s00769-006-0095-y]
[10]
AlOthman, Z.A.; Rahman, N.; Siddiqui, M.R. Review on pharmaceutical impurities,stability studies and degradation product. Rev. Adv. Sci. Eng., 2013, 2, 155-166.
[http://dx.doi.org/10.1166/rase.2013.1039]
[11]
Kogawa, A.C.; Mendonca, J.N.; Lopes, N.P.; Salgado, H.R.N. Stability-indicating thin-layer chromatographic method for determination of darunavir in complex darunavir–β-cyclodextrin in the presence of its degradation products. Anal. Methods, 2014, 6, 3689-3693.
[http://dx.doi.org/10.1039/C4AY00248B]
[12]
Kogawa, A.C.; Aguiar, F.A.; Gaitani, C.M.; Salgado, H.R.N. Validation of a stability indicating capillary electrophoresis method for the determination of darunavir in tablets and comparison with the infrared absorption spectroscopic method. World J. Pharm. Pharm. Sci., 2014, 3(6), 283-297.
[13]
Pereira, E.A.; Micke, G.A.; Tavares, M.F. Determination of antiretroviral agents in human serum by capillary electrophoresis. J. Chromatogr. A, 2005, 1091(1-2), 169-176.
[http://dx.doi.org/10.1016/j.chroma.2005.07.031] [PMID: 16395807]
[14]
Fan, B.; Stewart, J.T. Determinations of zidovudine/didanosine/nevirapine and zidovudine/didanosine/ritonavir in human serum by micellar electrokinetic chromatography. J. Pharm. Biomed. Anal., 2002, 30(4), 955-960.
[http://dx.doi.org/10.1016/S0731-7085(02)00392-8] [PMID: 12408885]
[15]
Kaduk, J.A. Powder X-ray diffraction of darunavir ethanolate. Int. Centre for Diffraction Data, 2015, 30(3), 298-299.
[16]
Kogawa, A.C.; Salgado, H.R.N. Development and validation of the infrared spectroscopy method for the determination of darunavir in tablets. J. Phys. Chem., 2013, 3(1), 1-6.
[17]
Mohammad, A.S.; Jadhav, B.; Rajender, B.; Raheem, S.A.; Bashir, M.A.; Sulthana, M.A. Optimization of UV spectrophotometric method for estimation of darunavir in bulk drug and tablet formulations. Inter. J. Pharm. Sci. and Nanotechnology., 2016, 9(4)
[18]
Reddy, Mp.; Ramireddy, N. Spectrophotometric estimation of darunavir in bulk and pharmaceutical formulations. Int. J. Chem. Sci., 2013, 614-618.
[19]
Fathima, N.; Brahmaiah, M.; Abdul Huq, G.; Raveendra Reddy, P. Development and validation of UV spectroscopic methods for simultaneous estimation of darunavir and rilpivirine HCl in tablet formulation. Int. J. Pharm. Pharmaceutical Res., 2017, 9(3), 282-292.
[20]
Nagulwar, V.P. Development of UV spectrophotometric first order derivative method for the simultaneous estimation of ritonavir and lopinavir in the combined tablet dosage form. Int. J. Pharm. Sci. Res., 2012, 3(7), 2317-2320.
[21]
Sangshetti, J.N. Spectrophotometric method for simultaneous estimation of lopinavir and ritonavir in bulk and tablet dosage form. Int. J. Chemtech Res., 2014, 6(1), 823-827.
[22]
Salunke, J.M.; Pawar, D.S.; Chavhan, V.D.; Ghante, M.R. Simultaneous UV spectrophotometric method for estimation of ritonavir and lopinavir in bulk and tablet dosage form. Der Pharmacia. Letter., 2013, 5(3), 156-162.
[23]
Damle, M.; Deosthali, A. UV-Spectrophotometric absorbance correction method and absorbance ratio method for the simultaneous estimation of ritonavir and darunavir ethanolate. World J. Pharma. Sci., 2016, 5(8)
[24]
Chiranjeevi, K.; Channabasavaraj, K.; Reddy, P. Development and validation of spectrophotometric method for quantitative estimation of ritonavir in bulk and pharmaceutical dosage forms. Int. J. Chemtech Res., 2011, 3(1), 58-62.
[25]
Nagano, D.; Araki, T.; Nakamura, T.; Yamamoto, K. Determination of intracellular darunavir by liquid chromatography coupled with fluorescence detection. J. Chromatogr. Sci., 2013, 1-5.
[PMID: 24190871]
[26]
Mohammad, H.A. Validated stability-indicating HPLC and HPTLC methods for the determination of ritonavir in bulk powder and in capsules. J. Food and Drug Anal, 2012, 963-973.
[27]
Gadhvi, M.; Bhandari, A.; Suhagia, B.; Rathod, I.; Desai, U.; Patwari, A.; Variya, K. Simultaneous determination of ritonavir and atazanavir in combined tablet dosage form by HPTLC. Asian J. Biomedical Pharm. Sci., 2012, 2(15), 15-19.
[28]
Nagendrakumar, A.; Battula, S.; Rao, M.V.B.; Validated, R.P. HPLC method for the determination of darunavir in bulk and pharmaceutical formulation. Res. J. Pharm. Biol. Chem. Sci., 2014, 5(3), 63-72.
[29]
Mane, M.B. RP-HPLC method for the determination of darunavir in bulk and pharmaceutical preparations. Int. J. Pharm. Sci. Rev. Res., 2013, 21(2), 20-23.
[30]
Patel, B.N. RP-HPLC method development and validation for estimation of darunavir ethanolate in tablet dosage form. Int. J. Pharm. Pharm. Sci., 2012, 4(3), 270-273.
[31]
Mohana, P.V. Development, validation & stress degradation studies of darunavir by reverse phase-high performance liquid chromatography. Int J. Pharm. Drug. Anal., 2016, 4(2), 64-71.
[32]
Karthik, A.; Rama, K.; Chenthilnathan, A. RP-HPLC method development, and validation for quantification of the darunavir ethanolate tablet dosage form. Der Pharmacia Lettre., 2016, 8(5), 291-296.
[33]
Ahmad, Z. Development of a validated RP-HPLC method for estimation of darunavir in spiked human plasma with UV detection. Int. Res. J. Pharm., 2016, 7(1), 24-28.
[http://dx.doi.org/10.7897/2230-8407.0714]
[34]
Bommella, M. Development and validation of a simple, sensitive, selective and stability-indicating RP-HPLC method for the determination of darunavir and cobicistatin pharmaceutical combined dosage forms. J. Pharm. Biomed. Sci., 2017, 12(4), 69-78.
[35]
Babu, G.R.; Rao, A.L.; Rao, J.V. Development and validation of novel HPLC method for estimation of darunavir in pharmaceutical formulations. Int. J. Res. Pharm. Chem., 2013, 3(2), 438-443.
[36]
Rizwan, S.H. A New and validated stability indicating RP-HPLC analysis of darunavir and cobicistatin bulk drug and tablet dosage form. Int. J. Pharm. Sci. Rev. Res., 2016, 36(1), 180-185.
[37]
Jain, H.K. Development and validation of an RP-HPLC method for estimation of darunavir ethanolate in bulk and tablets. Int. J. Pharm. Pharm. Sci., 2015, 7(10), 386-389.
[38]
Correa, J.C.R.; Serra, C.H.D.R.; Salgado, H.R.N. Stability study of darunavir ethanolate tablets applying a new stability-indicating HPLC method. Chromatogr. Res. Int., 2013.
[http://dx.doi.org/10.1155/2013/834173]
[39]
Reddy, B.V.R.; Jyothi, G.; Reddy, B.S.; Raman, N.V.; Reddy, K.S.; Rambabu, C. Stability-indicating HPLC method for the determination of darunavir ethanolate. J. Chromatogr. Sci., 2013, 51(5), 471-476.
[http://dx.doi.org/10.1093/chromsci/bms165] [PMID: 23097581]
[40]
Chaudhary, P.G. A validated stability-indicating a high-performance liquid chromatographic method for darunavir ethanolate tablet dosage form. Pharma. Tutor Magazine., 2014, 2(9), 91-100.
[41]
Maddinapudi, R. A selective and stability-indicating a high-performance liquid chromatographic method for estimation of isomers content in darunavir drug substance. Indo. American J. Pharm. Res., 2016, 6(4), 5267-5276.
[42]
Kiranmaie, S.G. Development and validation of stability indicating an RP-HPLC method for simultaneous estimation of darunavir and cobicistat in the pharmaceutical dosage form. Eur. J. Pharm. Med. Res., 2016, 3(12), 405-410.
[43]
Reddy, J.S.K.; Prasad, K.R.S.; Babu, K.S. A stability indicating the RP-HPLC method for simultaneous estimation of darunavir and cobicistat in bulk and tablet dosage form. Der. Pharmacia. Lettre., 2016, 8(12), 89-96.
[44]
Cerezo, G.E. A rapid validated UV- HPLC method for the simultaneous determination of the antiretroviral compounds darunavir and raltegravir their dosage form. Rev. Esp. Quimioter., 2017, 30(3), 183-194.
[PMID: 28440605]
[45]
Ghante, M. Development and validation of stability indicating a method for darunavir with forced degradation studies using LC-ESI-MS/MS. Asian J. Chem., 2016, 28(8), 1729-1733.
[http://dx.doi.org/10.14233/ajchem.2016.19806]
[46]
Mohammad, H.A. Validated stability-indicating HPLC and HPTLC methods for the determination of ritonavir in bulk powder and in capsules. J. Food Drug Anal., 2012, 20(4), 963-973.
[47]
Rao, V.B.; Vidyadhara, S.; Ram Babu, R.; Praveen Kumar, B.; Kishor Kumar, G. Analytical method development, and validation for simultaneous estimation of lopinavir and ritonavir by RP-HPLC. Int. J. Res. Dev. Pharm. L. Sci., 2014, 3(4), 1074-1079.
[48]
Vasavi, N.; Patan, A. Method development and validation for the simultaneous estimation of atazanavir and ritonavir in tablet dosage form by RP-HPLC. Ind. J. Res. Pharm. Biotechnol., 2013, 1(6), 808-814.
[49]
Gorja, A. Method development and validation for the simultaneous estimation of ritonavir and lopinavir in pharmaceutical dosage forms by RP-HPLC. World J. Pharma. Sci., 2014, 3(10), 694-702.
[50]
Hiremath, S.N. Development and validation of stability-indicating HPLC methods for the simultaneous analysis of lopinavir and ritonavir in fixed dose combination tablets. J. Taibah University Medical Sci., 2015, 10(3), 271-277.
[http://dx.doi.org/10.1016/j.jtumed.2014.11.006]
[51]
Sunitha, N. Method development and validation of stability indicating an RP-HPLC method for simultaneous estimation of ritonavir and lopinavir in the pure and pharmaceutical dosage form. Int. J. Adv. Res. (Indore), 2015, 3(5), 649-657.
[52]
Kumar, P.J.; Murthy, T.E.G.K.; Jithendra, R.; Nagaraju, P. A validated reverse phase HPLC method for the simultaneous estimation of lopinavir and ritonavir in pharmaceutical dosage forms. J. Pharm. Res., 2011, 4(8), 2819-2821.
[53]
Suneeth, A. kathirvel, S.; Ramchandrika, G. A validated RP HPLC method for simultaneous estimation of lopinavir and ritonavir in combined dosage form. Int. J. Pharm. Pharm. Sci., 2011, 3(1), 49-51.
[54]
Pawar, D.S.; Dole, M.; Salunke, J. Development and validation of RP-HPLC method for the simultaneous estimation of atazanavir sulphate and ritonavir in bulk and formulations. Int. J. Pharm. Pharm. Sci., 2013, 5(3), 905-909.
[55]
Kumar, K.V.; Sudhakar, M.; Reddy, P. RP-HPLC method development and validation for simultaneous estimation of lopinavir and ritonavir in dosage form and in plasma. Int. J. Pharm. Res. Rev., 2014, 3(9), 1-8.
[56]
Rao, V.B.; Vidyadhara, S.; Kumar, K.G. Analytical method development and validation for simultaneous estimation of lopinavir and ritonavir by RP-HPLC. Int. J. Res. Dev. Pharm. L. Sci., 2014, 3(4), 1074-1079.
[57]
Patel, B.N.; Patel, C.N. Simultaneous determination and validation of darunavir ethanolate ritonavir in the binary mixture by liquid chromatography. Int. J. Pharm. Tech. Res., 2012, 4(4), 1450-1456.
[58]
Sindu, P.D. Stability-indicating reversed-phase high-performance liquid chromatography method for the simultaneous estimation of darunavir and ritonavir. Asian J. Pharm. Clin. Res., 2016, 9(20), 71-76.
[59]
Patel, A.; Patel, A.; Makwana, A. An ESI-LC-MS/MS method for simultaneous estimation of darunavir and ritonavir in human plasma. Int. J. Res. Pharm. Biomed. Sci., 2013, 4(4), 1138-1147.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 5
Year: 2020
Published on: 15 June, 2020
Page: [447 - 455]
Pages: 9
DOI: 10.2174/1573412915666190206124808
Price: $65

Article Metrics

PDF: 17
HTML: 1